Latest Articles
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic - citybuzz -
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic citybuzz -
Published: Oct. 27, 2025, 9:33 p.m.
Aditxt (ADTX) Launches Clinical Study for Innovative Endometrios - GuruFocus
Aditxt (ADTX) Launches Clinical Study for Innovative Endometrios GuruFocus
Published: Oct. 27, 2025, 2:01 p.m.
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know - TipRanks
GSK’s New Clinical Study on Endometrial Cancer: What Investors Need to Know TipRanks
Published: Aug. 7, 2025, 4:23 p.m.
Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Quantisnow
Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Quantisnow
Published: April 16, 2025, 12:15 p.m.
Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 - Bluefield Daily Telegraph
Aditxt Subsidiary Pearsanta Receives IRB Approval to Initiate Clinical Study of Blood-Based Diagnostic for Endometriosis with Patient Enrollment Planned to Begin in May 2025 Bluefield Daily Telegraph
Published: April 16, 2025, 12:14 p.m.
Link copied to clipboard!